BioMarin Pharmaceutical Inc. (BMRN)

107.83
0.50 0.46
NASDAQ : Health Technology
Prev Close 108.33
Open 108.34
Day Low/High 107.39 / 108.95
52 Wk Low/High 62.88 / 109.51
Volume 275.10K
Avg Volume 1.74M
Exchange NASDAQ
Shares Outstanding 180.84M
Market Cap 19.42B
EPS -0.10
P/E Ratio 170.46
Div & Yield N.A. (N.A)
I'm Big on Housing Entering Quarter No. 2

I'm Big on Housing Entering Quarter No. 2

Home builders make up the second-largest allocation in my portfolio, behind biotech.

Biotech Should Witness M&A's Return in 2017

Biotech Should Witness M&A's Return in 2017

Drug giants with money to spend and a friendlier regulatory environment should spur deals.

BioMarin Surging Beneath the Surface

BioMarin Surging Beneath the Surface

The pharmaceutical stock is about to go from sideways to up.

Biomarin downgraded at Piper

Facebook Stands Out and FormFactor Has a Good Start

Facebook Stands Out and FormFactor Has a Good Start

Overall, this is still a good environment for stock picking.

Cramer: Companies Are Issuing a Lot of Paper

Cramer: Companies Are Issuing a Lot of Paper

They're striking while the iron is hottest to raise money, reduce debt.

Cramer: What Are You Thinking? It Should Be Long Term

Cramer: What Are You Thinking? It Should Be Long Term

That may be the best way to get through the notorious month of August.

Cramer: 11 Reasons Why the Market Turned

Cramer: 11 Reasons Why the Market Turned

All of these add up to a level of insecurity on the part of sidelined money.

Closing Bell: Humana Slumps on Deal Worries; U.S. Stocks Mixed

Closing Bell: Humana Slumps on Deal Worries; U.S. Stocks Mixed

A sharp selloff in crude kept stocks mostly in the red, though optimism ahead of Friday's jobs reports kept losses to a minimum on Thursday.

BioMarin Pharmaceuticals Jumps on Takeover Talk

BioMarin Pharmaceuticals Jumps on Takeover Talk

Biotech company BioMarin Pharmacuetical's shares are moving sharply higher on heavy volume in Friday's session.

Bret Jensen Reporting for Duty

Good morning -- Bret Jensen here! As always, it's good to be standing in for Doug Kass. It looks like the rollercoaster in the market will continue today. We had a nice rally on Wednesday, followed by a deep decline yesterday. And this morning, the ...

BioMarin Has Juice Left in the Tank

BioMarin Has Juice Left in the Tank

The big downtrend line was broken decisively.

Jim Cramer Says BioMarin Is the Last Bear Market

Jim Cramer Says BioMarin Is the Last Bear Market

TheStreet’s Action Alerts PLUS Portfolio Manager Jim Cramer is keeping an eye on shares of BioMarin Pharmaceutical.

BioMarin Pharmaceutical's Illness Could Be Cured

BioMarin Pharmaceutical's Illness Could Be Cured

BMRN could re-base in the weeks and months ahead as downside looks limited. 

Teva, Biomarin Offer Convertible Opportunities Says MainStay Manager

Teva, Biomarin Offer Convertible Opportunities Says MainStay Manager

The convertible bond market has been fairly flat in 2015, closely following the slim returns seen in equities.

Stock Futures Move Higher; Cramer Is Watching GameStop 3Q Earnings

Also, Pfizer-Allergan deal clears another hurdle.

Grasping at Growth: The Hunt Is On

Grasping at Growth: The Hunt Is On

Once again, buyers are going for the gusto.

The Dems Will Bash Big Pharma Tonight

Drug companies are just too big a target to ignore.

Even Stocks With Bullish Outlooks Are Not Safe in the Market Carnage

Even Stocks With Bullish Outlooks Are Not Safe in the Market Carnage

Which means interest rate hikes are being built into prices.

The Trader Daily: Let's Welcome Biotechs to the House of Pain

The Trader Daily: Let's Welcome Biotechs to the House of Pain

The bulls can show them around the place.

Jim Cramer Won't Turn on Apple, Doesn't Like Twitter Until $19.20

Jim Cramer Won't Turn on Apple, Doesn't Like Twitter Until $19.20

Jim Cramer answers viewers' Twitter questions from the floor of the New York Stock Exchange.

Futures Tick Higher; Obama Pushes Emissions Reductions

Futures Tick Higher; Obama Pushes Emissions Reductions

Coal and renewables could both react as political and legal battles ensue.

BioMarin Is Ready for Primetime

BioMarin Is Ready for Primetime

BioMarin's chart has a well-defined uptrend line and shows great relative strength.

Biotech Stocks Are Booming

Biotech Stocks Are Booming

I like BioMarin because it has more upside and solid Relative Strength.

Biomarin downgraded at Baird

Can Biotechs' Relative Strength Be Trusted? 6 Stocks to Watch

Can Biotechs' Relative Strength Be Trusted? 6 Stocks to Watch

Sector may not be as bulletproof as we thought.

3 Biotechs That Are Worth Buying

Many of these stocks are off to the races.

Here's What's Driving Biotech

And it's not the favorable macroeconomic climate.

Answering Your Tweets

An answer to those asking me what's worth buying.